Cancer News and Research

Latest Cancer News and Research

Tool reveals myeloproliferative neoplasm patient burden

Researchers have devised a tool to accurately assess the extent of symptoms in patients with myeloproliferative neoplasms.

17 Oct 2012

Genetic signatures for aggressive prostate cancer identified

Researchers have identified two genetic signatures for castration-resistant prostate cancer that may predict the severity of the disease.

17 Oct 2012

HIV infection has been major driver of anal cancer burden

Rising rates of anal cancer among men in the USA have been heavily influenced by the HIV epidemic since the 1980s, a study shows.

17 Oct 2012

Quitting smoking may improve HRQoL in advanced lung cancer

The health-related quality of life of patients with advanced-stage lung cancer is worsened if they smoke, report UK researchers.

17 Oct 2012

DNA damage response contains previously unknown components: Study

Researchers at Moffitt Cancer Center and colleagues at the University of South Florida; Duke University; Johns Hopkins University; the Brazilian National Cancer Institute; and the Rio de Janeiro Federal Institute of Education, Science and Technology have discovered that an intricate system to repair DNA damage called the "DNA damage response" (DDR) contains previously unknown components, including proteins that could be targeted as sensitizers for chemotherapy.

17 Oct 2012

UMB, UMCP to develop small robot that could help neurosurgeons in removing brain tumors

A research team from the University of Maryland, College Park (UMCP) and the University of Maryland, Baltimore (UMB) have been awarded a new $2 million grant from the National Institutes of Health (NIH) to continue developing a small robot that could one day be a huge aid to neurosurgeons in removing difficult-to-reach brain tumors.

17 Oct 2012

Study finds nearly 10-fold increase in eye injuries during robotic-assisted radical prostatectomy

A study presented at the ANESTHESIOLOGY 2012 annual meeting found that during the years 2000-2009, eye injuries during robotic-assisted radical prostatectomy (RARP) increased nearly 10-fold, from a .07 percent incidence rate to .42 percent.

17 Oct 2012

Universal tumor testing superior to selective strategy in identifying Lynch syndrome among CRC patients

In a comparison of strategies to identify individuals with Lynch syndrome, the most common form of hereditary colorectal cancer (CRC), caused by mutations in certain genes (DNA mismatch repair [MMR] genes), universal tumor MMR testing among certain CRC patients had a greater sensitivity for the identification of Lynch syndrome compared with multiple alternative strategies, although the diagnostic improvement was modest, according to a study in the October 17 issue of JAMA.

17 Oct 2012

Stat5 protein could serve as biomarker to help guide prostate cancer treatment

Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent study published in Human Pathology by Jefferson's Kimmel Cancer Center researchers.

17 Oct 2012

FGF21 hormone markedly increases life span in mice

A study by UT Southwestern Medical Center researchers finds that a starvation hormone markedly extends life span in mice without the need for calorie restriction.

17 Oct 2012

Study determines how Trop2 protein drives growth of tumor cells in prostate and other epithelial cancers

Researchers led by Tanya Stoyanova and Dr. Owen Witte of UCLA's Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have determined how a protein known as Trop2 drives the growth of tumor cells in prostate and other epithelial cancers.

17 Oct 2012

Salk findings on cold virus proteins may spur new cancer treatments

Cold viruses generally get a bad rap----which they've certainly earned----but new findings by a team of scientists at the Salk Institute for Biological Studies suggest that these viruses might also be a valuable ally in the fight against cancer.

17 Oct 2012

EMR before radiofrequency ablation safe and effective for patients with nodular Barrett's esophagus

A new study shows that endoscopic mucosal resection (EMR) before radiofrequency ablation (RFA) is a safe and effective treatment option for patients with nodular Barrett's esophagus (BE) and advanced neoplasia.

17 Oct 2012

Researchers identify critical mechanisms of epigenetic cell programming

A team of researchers at the IRCM, supervised by Dr. Jacques Drouin, reprogrammed the identity of cells in the pituitary gland and identified critical mechanisms of epigenetic cell programming.

17 Oct 2012

FDA accepts A.P. Pharma’s resubmission of NDA for APF530

A.P. Pharma, Inc., a specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Company's resubmission of its New Drug Application (NDA) for APF530.

17 Oct 2012

NIH honors Scripps Florida postdoctoral fellow with Pathway to Independence Award

The career of Antonio (Tony) Amelio, a postdoctoral fellow in the Department of Cancer Biology at The Scripps Research Institute, has gotten a boost from the National Institutes of Health in the form of a Howard Temin Pathway to Independence Award in Cancer Research.

17 Oct 2012

Robert Wood Johnson Foundation announces winners of 2012 Community Health Leaders Award

The Robert Wood Johnson Foundation is proud to announce today the recipients of its 2012 Community Health Leaders Award, honoring 10 individuals who have surmounted significant challenges to help improve health and health care in their communities.

17 Oct 2012

Saint Mary's, Mercy Health and VAI sign agreements to expand biorepository

Van Andel Institute (VAI) and two West Michigan hospitals within the national Trinity Health system and members of Mercy Health - Saint Mary's Health Care and Mercy Health Partners - have signed agreements paving the way for the expansion of a world-class biorepository utilizing the infrastructure of the VAI Program for Biospecimen Science.

17 Oct 2012

Recurrent patterns of genomic imbalances determine evolution of invasive breast cancer

Ductal carcinoma in situ (DCIS) is considered a precursor lesion for invasive breast cancer if untreated, and is found in approximately 45% of patients with invasive ductal carcinoma (IDC). Patients with DCIS only (not accompanied by invasive disease) have a 5-year-survival of nearly 100%, compared to 89% for all stages of invasive breast cancer (24% for patients with distant metastasis).

17 Oct 2012

Patient-reported outcomes should be assessed in comparative effectiveness of cancer treatments

Patient-reported outcomes should be a standard part of evaluating the comparative effectiveness of cancer treatments, according to recommendations put forward by a multi-institution research group.

17 Oct 2012

Cancer News and Research

Latest Cancer News and Research

Tool reveals myeloproliferative neoplasm patient burden

Genetic signatures for aggressive prostate cancer identified

HIV infection has been major driver of anal cancer burden

Quitting smoking may improve HRQoL in advanced lung cancer

DNA damage response contains previously unknown components: Study

UMB, UMCP to develop small robot that could help neurosurgeons in removing brain tumors

Study finds nearly 10-fold increase in eye injuries during robotic-assisted radical prostatectomy

Universal tumor testing superior to selective strategy in identifying Lynch syndrome among CRC patients

Stat5 protein could serve as biomarker to help guide prostate cancer treatment

FGF21 hormone markedly increases life span in mice

Study determines how Trop2 protein drives growth of tumor cells in prostate and other epithelial cancers

Salk findings on cold virus proteins may spur new cancer treatments

EMR before radiofrequency ablation safe and effective for patients with nodular Barrett's esophagus

Researchers identify critical mechanisms of epigenetic cell programming

FDA accepts A.P. Pharma’s resubmission of NDA for APF530

NIH honors Scripps Florida postdoctoral fellow with Pathway to Independence Award

Robert Wood Johnson Foundation announces winners of 2012 Community Health Leaders Award

Saint Mary's, Mercy Health and VAI sign agreements to expand biorepository

Recurrent patterns of genomic imbalances determine evolution of invasive breast cancer

Patient-reported outcomes should be assessed in comparative effectiveness of cancer treatments

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Newsletters you may be interested in